AAV2-Mediated Gene Therapy for Choroideremia: 5-Year Results and Alternate Anti-sense Oligonucleotide Therapy. Zhai Y, Xu M, Radziwon A, Dimopoulos IS, et al. Am J Ophthalmol 2023;248:145-156.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhai Y, Xu M, Radziwon A, Dimopoulos IS, et al. AAV2-Mediated Gene Therapy for Choroideremia: 5-Year Results and Alternate Anti-sense Oligonucleotide Therapy. Am J Ophthalmol 2023;248:145-156.
PMID: 36581191